Publication | Open Access
Cefiderocol use for the treatment of infections by carbapenem-resistant Gram-negative bacteria: an Italian multicentre real-life experience
25
Citations
26
References
2023
Year
Real-life data confirm that cefiderocol is a promising option against carbapenem-resistant Gram-negative infections, even as monotherapy.
| Year | Citations | |
|---|---|---|
Page 1
Page 1